| Primary |
| Drug Use For Unknown Indication |
35.5% |
| Product Used For Unknown Indication |
8.4% |
| Helicobacter Infection |
7.9% |
| Streptococcal Infection |
6.6% |
| Kawasaki's Disease |
5.1% |
| Hypertension |
3.8% |
| Urinary Tract Infection |
3.8% |
| Bronchitis |
3.6% |
| Convulsion |
3.0% |
| Duodenal Ulcer |
2.5% |
| Infection |
2.3% |
| Upper Respiratory Tract Infection |
2.3% |
| Wound Infection |
2.3% |
| Erysipelas |
2.0% |
| Nasopharyngitis |
2.0% |
| Tonsillitis |
2.0% |
| Endocarditis |
1.8% |
| Pharyngitis |
1.8% |
| Toothache |
1.8% |
| Diabetes Mellitus |
1.5% |
|
| Rash |
11.2% |
| Urticaria |
11.2% |
| Renal Failure Acute |
8.6% |
| Toxic Epidermal Necrolysis |
6.9% |
| Vomiting |
6.9% |
| Toxic Skin Eruption |
6.0% |
| Serum Sickness |
5.2% |
| White Blood Cell Count Decreased |
5.2% |
| Rash Erythematous |
4.3% |
| Stevens-johnson Syndrome |
4.3% |
| Haematochezia |
3.4% |
| Pyrexia |
3.4% |
| Thrombocytopenia |
3.4% |
| Type Iv Hypersensitivity Reaction |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Asthma |
2.6% |
| Generalised Erythema |
2.6% |
| Jaundice Cholestatic |
2.6% |
| Klebsiella Infection |
2.6% |
| Liver Injury |
2.6% |
|
| Secondary |
| Helicobacter Infection |
28.7% |
| Product Used For Unknown Indication |
17.4% |
| Drug Use For Unknown Indication |
15.4% |
| Helicobacter Gastritis |
8.3% |
| Duodenal Ulcer |
6.3% |
| Prophylaxis |
2.5% |
| Essential Hypertension |
2.1% |
| Toothache |
2.0% |
| Bronchitis |
1.8% |
| Pyrexia |
1.8% |
| Constipation |
1.7% |
| Gastric Ulcer |
1.6% |
| Otitis Media Acute |
1.5% |
| Cough |
1.4% |
| Duodenitis |
1.4% |
| Ulcer |
1.4% |
| Anxiety |
1.2% |
| Viral Infection |
1.2% |
| Aphthous Stomatitis |
1.1% |
| Cardiovascular Disorder |
1.1% |
|
| Inappropriate Antidiuretic Hormone Secretion |
11.2% |
| Renal Failure Acute |
8.2% |
| Vomiting |
8.2% |
| Drug Eruption |
6.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.2% |
| Laryngeal Oedema |
5.2% |
| Skin Test Positive |
5.2% |
| Toxic Epidermal Necrolysis |
5.2% |
| Vertigo |
5.2% |
| Erythema Multiforme |
4.5% |
| Thrombocytopenia |
4.5% |
| Toxic Skin Eruption |
4.5% |
| Agranulocytosis |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| X-ray Abnormal |
3.7% |
| Acute Generalised Exanthematous Pustulosis |
3.0% |
| Bronchospasm |
3.0% |
| Coagulation Factor V Level Decreased |
3.0% |
| Jaundice |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.3% |
| Drug Use For Unknown Indication |
13.8% |
| Asthma |
10.3% |
| Parkinson's Disease |
7.4% |
| Hypertension |
6.7% |
| Prophylaxis |
6.3% |
| Multiple Myeloma |
5.0% |
| Bronchitis |
4.5% |
| Ill-defined Disorder |
3.7% |
| Pneumonia |
3.6% |
| Otitis Media |
3.2% |
| Helicobacter Infection |
3.0% |
| Upper Respiratory Tract Inflammation |
2.5% |
| Depression |
2.1% |
| Diabetes Mellitus |
2.1% |
| Pain |
2.0% |
| Tonsillitis |
2.0% |
| Hiv Infection |
1.9% |
| Antiviral Treatment |
1.8% |
| Pharyngitis |
1.8% |
|
| Wrong Drug Administered |
9.4% |
| Renal Failure Acute |
8.3% |
| Sinusitis |
7.3% |
| Pyrexia |
6.3% |
| Urinary Tract Infection |
6.3% |
| Wheezing |
6.3% |
| Medication Error |
5.2% |
| Vomiting |
5.2% |
| Intestinal Obstruction |
4.2% |
| Off Label Use |
4.2% |
| Sepsis |
4.2% |
| Stillbirth |
4.2% |
| Thrombotic Microangiopathy |
4.2% |
| Toxic Skin Eruption |
4.2% |
| Urinoma |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Lung Disorder |
3.1% |
| Metabolic Acidosis |
3.1% |
| Rash |
3.1% |
| Suicide Attempt |
3.1% |
|
| Interacting |
| Helicobacter Gastritis |
24.0% |
| Bacterial Infection |
16.0% |
| Bronchitis |
8.0% |
| Encephalitis Viral |
8.0% |
| Neoplasm Prophylaxis |
8.0% |
| Peripheral T-cell Lymphoma Unspecified |
8.0% |
| Pyrexia |
8.0% |
| Respiratory Tract Infection |
8.0% |
| Urinary Tract Infection |
8.0% |
| Panniculitis |
4.0% |
|
| Clostridium Difficile Colitis |
33.3% |
| Sepsis |
33.3% |
| International Normalised Ratio Increased |
16.7% |
| Salpingitis |
16.7% |
|
